Related Experiment Video
Updated: Mar 8, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Monomethyltransferase SETD8 regulates breast cancer metabolism via stabilizing hypoxia-inducible factor 1α
Run Huang1, Yang Yu2, Xiangyun Zong1
1Department of Breast Surgery, Shanghai Jiao Tong University Affiliated Shanghai Sixth People's Hospital, 600 Yishan Road, Shanghai 200233, China.
Abstract:
SETD8 is a methyltransferase that specifically catalyzes the monomethylation of lysine 20 on histone H4. Previous studies have demonstrated that SETD8 is associated with proper cell cycle progression, DNA damage response, and transcriptional regulation. A recent study revealed that SETD8 played an important role in epithelial-mesenchymal transition (EMT) in association with TWIST and enhanced metastatic potential of breast cancer cells. However, the contribution of SETD8 to metabolism reprogramming, one hallmark of cancer, has never been reported. In this study, we report that SETD8 was a positive regulator of anabolic metabolism. SETD8 reprograms breast cancer cell metabolism through hypoxia-inducible factor 1α (HIF1α) mediated process. Mechanistic studies indicated that SETD8 stabilized HIF1α protein level through post-transcriptional regulation. Moreover, we demonstrated that SETD8 was a HIF1α transcription target. In clinical breast cancer patient tissues, we observed a positive correlation of SETD8 with HIF1α and HIF1α target genes. Taken together, we validated SETD8 as a novel metabolic reprogramming regulator, and our mechanistic studies shed light on a novel function of SETD8 in breast cancer malignant properties maintenance.
Insights
The study reveals SETD8 (SET Domain Containing 8) regulates anabolic metabolism in breast cancer by stabilizing hypoxia-inducible factor 1α (HIF1α). This highlights SETD8
Area of Science:
- Epigenetics and Cancer Metabolism
- Molecular Biology
- Biochemistry
Background:
- SETD8 (SET Domain Containing 8) is a histone methyltransferase regulating cell cycle and DNA repair.
- Previous research linked SETD8 to epithelial-mesenchymal transition (EMT) and breast cancer metastasis.
- The role of SETD8 in cancer metabolism reprogramming remained unexplored.
Purpose of the Study:
- To investigate the role of SETD8 in metabolic reprogramming in breast cancer.
- To elucidate the molecular mechanisms by which SETD8 influences cancer metabolism.
- To explore the clinical relevance of SETD8 in breast cancer patients.
Main Methods:
- Cell-based assays to assess metabolic changes.
- Western blotting and qRT-PCR to analyze protein and gene expression.
- Analysis of clinical breast cancer patient tissues.
Main Results:
- SETD8 acts as a positive regulator of anabolic metabolism in breast cancer cells.
- SETD8 reprograms metabolism via a hypoxia-inducible factor 1α (HIF1α)-dependent pathway.
- SETD8 stabilizes HIF1α protein levels through post-transcriptional regulation and is a HIF1α target gene.
- A positive correlation between SETD8, HIF1α, and HIF1α target genes was observed in clinical samples.
Conclusions:
- SETD8 is identified as a novel regulator of metabolic reprogramming in breast cancer.
- The SETD8-HIF1α axis plays a crucial role in maintaining breast cancer malignancy.
- These findings offer new insights into the functions of SETD8 in cancer progression.
More Related Videos
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Epigenetic Regulation
X-chromosome...